Novartis raises full year core operating income guidance — ChemBrief Topics
Novartis raises full year core operating income guidance
Oct 26, 2026
Novartis raised its full-year core operating income guidance to low single-digit growth after strong third-quarter demand for key cancer and multiple sclerosis drugs.